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 Dengue Fever 
By: Ashley Hernandez and  Chris Harkness 
 
Background 
Importance: In recent years, the transmission of  dengue fever 
has increased surprisingly fast and has become a major international 
public health concern. As of today this disease has mainly affected 
large countries and has become a leading cause of hospitalization 
and death among children in the certain areas. The amount of people 
that have got this infection has dramatically increase in recent 
decades. Over 40% of the world’s population are currently at risk of 
getting Dengue Fever. There is now an estimate of 50-100 million 
people that catch this disease every year (World Health  
Organization, 2002). 
 
 
 
 
 
 
 
 
 
Historical: In the 1970s there were only 9 countries that had 
dengue fever and now there are about 100 countries in  the region of 
the West Pacific. Not only are the number of cases is increasing, but 
large outbreaks are also occurring worldwide. Now the threat of 
possible outbreak of dengue fever is in Europe. As this virus spread 
to 20 different countries, it managed to hospitalize an estimated 
500,000 people each year and approximately 2.5% of these people 
die ( World  Health Organization, 2002). 
 
 
 
 
 
 
Microorganism/information:  Dengue fever is caused by 
viruses, and there is not a specific type of medicine or antibiotic that 
could treat it. This virus is able to live only within the living cells of 
the hosts. During a ten day incubation time period, the virus passes 
from intestinal tract to the salivary glands. This is how the person 
gets infected and the mosquito that is carrying the dengue fever virus 
can live for about a month infecting thousands more people ( World 
Health Organization, 2002). 
 
Infection/Disease 
Immune Response: Dengue fever is a RNA Virus. Its outer 
bilayer contains capsid shell containing the RNA genome. The 
cognate receptor is involved in normal infection and the Fc receptor 
is involve with a phenomenon called and antibody dependent 
enhancement. The protein combines to the cognate receptor and 
triggers a cellular process called cytosis. The virus responds by 
changing the form of the outer shape from protein to spikes. The 
capsid breaks and the viral RNA travels to the rough endoplasmic 
reticulum. The RNA attaches to the replication complex to start the 
first round of synthesis. Using the virus’s positive sense RNA as the 
template a negative copy is made, the pair of RNA strands forms a 
double helix. The RNA then become a circle again (Clark, 1955). 
 
 
 
 
 
 
 
 
Progression: Mosquitoes carry this virus and then transmit it 
inside humans.  Unlike common colds dengue fever can only be 
passed down by an infection. Once the virus has been transmitted 
into the body, it travels inside the blood stream and can cause 
changes to the blood vessels.  A process called disseminated 
intravascular coagulation (DIC) occurs, where chemicals 
responsible for clotting are used up which leads to severe bleeding 
(Gubler, 2003). 
 
 
 
 
Prognosis: For the large majority of people that have been 
infected with dengue fever, the prognosis is excellent. During the 
illness, the patients are likely to feel extreme pain. Patients with 
underlying illness or immune depression have a fair to good 
prognosis because they are more likely to get complications. 
Patients who develop Dengue Hemorrhagic Fever or Dengue Shock 
Syndrome have a range of outcomes from good to poor, depending 
on how quickly supportive measures are given. Overall, the rate 
worldwide is about 1% of all dengue fever which  means that 
around 500,000 to 1 million people die each year from dengue fever 
(Whitethorn, 2012). 
Treatment 
Options:  There has not been a single vaccine made to cure 
dengue fever. The only treatment doctors advocate is reducing 
the extreme pain the person is consumed with. Doctors give 
their patients precaution to not use NSAIDS (non-steroidal-anti-
inflammatory-drugs) such as pain reliever, or any aspirin 
containing drugs because it can increase the risk of internal 
bleeding. Most patients are advised to use Tylenol. As with the 
dengue virus, DHF (Dengue Hemimorphic Fever) also causes 
extreme pain.  If a client is diagnosed at an early stage with 
DHF, the symptoms can be treated effectively by using fluid 
replacement therapy (Clark 1955). 
 
 
 
Mechanism: The white blood cells respond by producing 
signaling proteins; such as cytokines and interferon, which are 
responsible for many symptoms including the flu-like symptoms 
and the severe pain. In severe infections, the virus inside the 
victim’s body has greatly increased and a higher chance exists 
that many other organs could be affected.. As a result; less blood 
is able to circulate into the blood vessels, and the blood pressure 
becomes dangerously low and cannot supply sufficient blood to 
vital organs. Dysfunction of the bone marrow which is a result 
of the infection of stromal cells, leads to reduced numbers of 
platelets, which are necessary for proper blood clotting (Sandler, 
1998). 
 
 
 
 
 
Emerging:: In dengue fever there is the leaking blood vessel 
that needs to be understood to be able to conquer this illness. 
Dengue is a disease of dehydration, so doctors recommend to 
stay hydrated and drink plenty of fluids for treatment.  If a 
patient does not stay hydrated, the arteries and veins may 
develop thousands of pinpoint holes due to the body's reaction to 
the dengue virus. As this occurs, the fluids from inside the blood 
vessels to leak out (Shimmer, 2005). 
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